Rolf Ljung
111 – 120 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
42. Blödningssjukdomar och tromboser
2010) p.331-337(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
Prophylactic therapy in haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
-
Mark
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
(
- Contribution to journal › Article
-
Mark
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC.
(
- Contribution to journal › Article
- 2008
-
Mark
Venous access - why such diverse experiences of central venous lines?
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96(
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5(
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
(
- Contribution to journal › Article
-
Mark
Management of carriers and babies with haemophilia
(
- Contribution to journal › Article
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
(
- Contribution to journal › Article